Trademark: 88318048
Status Date
Tuesday, October 8, 2019
Registration Number
5878488
Registration Date
Tuesday, October 8, 2019
Filing Date
Wednesday, February 27, 2019
Published for Opposition
Tuesday, July 23, 2019
5 Pharmaceutical preparations for medical use, namely, pharmaceutical preparations for immunoregulation, for treatment of autoimmune diseases, for use as anti-cancer agents, for treatment of cancer, for treatment of tumors, for treatment of central nervous system disorders and for treatment of metabolic diseases; pharmaceutical preparations for treating human immune diseases and conditions; pharmaceutical preparations for treating inflammatory diseases and conditions; pharmaceutical preparations for treating arthritis; pharmaceutical preparations for treating rheumatoid arthritis; pharmaceutical preparations for treating psoriatic arthritis; pharmaceutical preparations for treating ankylosing spondylitis; pharmaceutical preparations for treating psoriasis; pharmaceutical preparations for treating polyarticular juvenile idiopathic arthritis; pharmaceutical preparations for treating enthesitis-related arthritis
Oct 8, 2019
Registered-Principal Register
Jul 23, 2019
Official Gazette Publication Confirmation E-Mailed
Jul 23, 2019
Published For Opposition
Jul 3, 2019
Notification Of Notice Of Publication E-Mailed
Jun 19, 2019
Approved For Pub - Principal Register
Jun 17, 2019
Teas/Email Correspondence Entered
Jun 17, 2019
Correspondence Received In Law Office
Jun 13, 2019
Assigned To Lie
Jun 7, 2019
Teas Response To Suspension Inquiry Received
Mar 29, 2019
Notification Of Letter Of Suspension E-Mailed
Mar 29, 2019
Letter Of Suspension E-Mailed
Mar 29, 2019
Suspension Letter Written
Mar 29, 2019
Examiner's Amendment Entered
Mar 29, 2019
Notification Of Examiners Amendment E-Mailed
Mar 29, 2019
Examiners Amendment E-Mailed
Mar 29, 2019
Examiners Amendment -Written
Mar 26, 2019
Assigned To Examiner
Mar 18, 2019
New Application Office Supplied Data Entered In Tram
Mar 2, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24